A detailed history of Tctc Holdings, LLC transactions in Organon & Co. stock. As of the latest transaction made, Tctc Holdings, LLC holds 1,830 shares of OGN stock, worth $27,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,830
Previous 1,842 0.65%
Holding current value
$27,029
Previous $38,000 7.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$18.65 - $23.03 $223 - $276
-12 Reduced 0.65%
1,830 $35,000
Q2 2024

Aug 05, 2024

SELL
$17.45 - $21.96 $17 - $21
-1 Reduced 0.05%
1,842 $38,000
Q1 2024

May 09, 2024

SELL
$13.78 - $18.8 $537 - $733
-39 Reduced 2.07%
1,843 $34,000
Q4 2023

Feb 08, 2024

SELL
$10.95 - $17.32 $9,110 - $14,410
-832 Reduced 30.66%
1,882 $27,000
Q2 2023

Aug 10, 2023

SELL
$19.27 - $24.63 $3,487 - $4,458
-181 Reduced 6.25%
2,714 $56,000
Q1 2023

May 12, 2023

SELL
$21.42 - $32.08 $8,910 - $13,345
-416 Reduced 12.56%
2,895 $68,000
Q4 2022

Feb 10, 2023

BUY
$23.31 - $28.61 $745 - $915
32 Added 0.98%
3,311 $92,000
Q3 2022

Nov 09, 2022

SELL
$23.4 - $34.25 $912 - $1,335
-39 Reduced 1.18%
3,279 $77,000
Q2 2022

Aug 11, 2022

SELL
$31.66 - $38.9 $44,324 - $54,460
-1,400 Reduced 29.67%
3,318 $112,000
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $5,450 - $7,045
-179 Reduced 3.66%
4,718 $165,000
Q4 2021

Feb 09, 2022

SELL
$28.67 - $37.13 $54,960 - $71,178
-1,917 Reduced 28.13%
4,897 $150,000
Q3 2021

Nov 04, 2021

SELL
$28.63 - $35.64 $349,286 - $434,808
-12,200 Reduced 64.16%
6,814 $223,000
Q2 2021

Aug 11, 2021

BUY
$28.45 - $38.0 $540,948 - $722,532
19,014 New
19,014 $576,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Tctc Holdings, LLC Portfolio

Follow Tctc Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.